Current IACM-Bulletins
The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.
[IACM Homepage] [IACM-Bulletin Year 2021] [2020] [2019] [2018] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
- IACM-Bulletin of 24 April 2022
- Science/Human: Cannabis may be helpful in inflammatory bowel disease according to survey
- Science/Human: The legalisation of cannabis for adults may be associated with reduced prescription drug use
- Science/Human: A cannabis extract was superior to long acting opiates in patients with neuropathic back pain
- IACM-Bulletin of 10 April 2022
- IACM: The Cannabinoid Conference 2022 is dedicated to Daniela Parolaro
- IACM: Former Chairwoman Daniela Parolaro passed away
- USA: House of Representatives supports the legalisation of cannabis, but the bill faces dim prospects in the Senate
- Science/Human: THC reduces opioid use in older pain patients even in low doses
- Science/Human: The legalisation of cannabis in the USA did not increase cannabis-related treatments
- Science/Human: Cannabidivarin may be effective in the treatment of epilepsy in girls with Rett syndrome
- IACM-Bulletin of 27 March 2022
- Science/Human: Cannabis may be helpful in Tourette syndrome according to an open study
- Science/Human: The anxiolytic effect of CBD depends on the nature of trauma in post-traumatic stress disorder
- Science/Human: Cannabis is effective in the treatment of nausea according to self-reports
- Science/Human: Cannabis use is common in patients with hair loss and helps them cope with anxiety and depression
- IACM-Bulletin of 13 February 2022
- USA: Mississippi becomes the 37th state to legalise the medical use of cannabis
- Science/Human: Cannabis may be helpful in the treatment of chronic migraine according to a retrospective study
- Science/Human: A cannabis extract and pure THC reduce pain according to two analyses from the German Pain e-Registry
- Science/Human: Patients with neuropathic pain may benefit from a treatment with cannabis
- Science/Human: Cannabis use is associated with decreased mortality in trauma patients
- IACM-Bulletin of 16 January 2022
- Science/Cells: Cannabinoids may have the potential to prevent and treat infection by the new coronavirus
- Science/Human: Among older adults in Canada medicinal cannabis products are more often used by women than by men
- Science/Human: Cannabis is used for a variety of medical reasons in the USA and Canada
- Science/Human: Fatal outcome in a clinical study with the new FAAH inhibitor in healthy adults
- IACM-Bulletin of 02 January 2022
- Science/Human: The medical use of cannabis may be helpful in severe treatment resistant epilepsy
- Science/Human: CBD in addition to THC in cannabis cigarettes reduces anxiety while keeping positive subjective effects
- Science/Animal: CBD inhibits growth of glioblastoma by altering the tumour microenvironment among other mechanisms
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be postponed to autumn 2022 and will be held as a hybrid event in Switzerland and online.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.